BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2369366)

  • 1. Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity.
    Aviram M; Dankner G; Brook JG
    Arteriosclerosis; 1990; 10(4):559-63. PubMed ID: 2369366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein.
    Hussein O; Brook GJ; Aviram M
    Isr J Med Sci; 1993 Aug; 29(8):453-9. PubMed ID: 8407271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteins derived from platelet alpha granules modulate the uptake of oxidized low density lipoprotein by macrophages.
    Fuhrman B; Brook GJ; Aviram M
    Biochim Biophys Acta; 1992 Jul; 1127(1):15-21. PubMed ID: 1385728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation.
    Aviram M
    Thromb Haemost; 1995 Jul; 74(1):560-4. PubMed ID: 8578524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated platelets secrete a protein-like factor that stimulates oxidized-LDL receptor activity in macrophages.
    Fuhrman B; Brook GJ; Aviram M
    J Lipid Res; 1991 Jul; 32(7):1113-23. PubMed ID: 1940635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-protein particles secreted from activated platelets reduce macrophage uptake of low density lipoprotein.
    Fuhrman B; Brook GJ; Aviram M
    Atherosclerosis; 1991 Aug; 89(2-3):163-73. PubMed ID: 1793444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells.
    Aviram M
    J Biol Chem; 1992 Jan; 267(1):218-25. PubMed ID: 1730591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet secreted lipoprotein-like particle is taken up by the macrophage scavenger receptor and enhances cellular cholesterol accumulation.
    Maor I; Brook GJ; Aviram M
    Atherosclerosis; 1991 Jun; 88(2-3):163-74. PubMed ID: 1892483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.
    Aviram M; Dankner G; Cogan U; Hochgraf E; Brook JG
    Metabolism; 1992 Mar; 41(3):229-35. PubMed ID: 1542259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin increases macrophage uptake of oxidized low density lipoprotein.
    Aviram M; Fuhrman B; Maor I; Brook GJ
    Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):55-61. PubMed ID: 1581411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein.
    Keidar S; Brook GJ; Rosenblat M; Fuhrman B; Dankner G; Aviram M
    Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages.
    Roma P; Catapano AL; Bertulli SM; Varesi L; Fumagalli R; Bernini F
    Biochem Biophys Res Commun; 1990 Aug; 171(1):123-31. PubMed ID: 2393386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL.
    Fuhrman B; Judith O; Keidar S; Ben-Yaish L; Kaplan M; Aviram M
    Free Radic Biol Med; 1997; 23(1):34-46. PubMed ID: 9165295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
    Maor I; Mandel H; Aviram M
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of LDL by platelet secretory products induces enhanced uptake and cholesterol accumulation in macrophages.
    Fuhrman B; Maor I; Rosenblat M; Dankner G; Aviram M; Brook JG
    Biochem Med Metab Biol; 1989 Aug; 42(1):9-20. PubMed ID: 2775565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation.
    Aviram M; Fuhrman B; Keidar S; Maor I; Rosenblat M; Dankner G; Brook G
    J Clin Chem Clin Biochem; 1989 Jan; 27(1):3-12. PubMed ID: 2498457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet-modified LDL: uptake and metabolism in macrophages].
    Fuhrman B; Brook JG; Aviram M
    Harefuah; 1989 Oct; 117(7-8):177-81. PubMed ID: 2583601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages.
    Aviram M
    Metabolism; 1989 May; 38(5):425-30. PubMed ID: 2725280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malondialdehyde affects the physico-chemical and biological characteristics of oxidized low density lipoprotein.
    Aviram M
    Atherosclerosis; 1990 Oct; 84(2-3):141-3. PubMed ID: 2282095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake.
    Kaplan M; Aviram M
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):386-93. PubMed ID: 11231918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.